* Delmar Pharmaceuticals and MD Anderson Initiate new phase two clinical trial of VAL-083 for mgmt-unmethylated recurrent Glioblastoma Multiforme
* Delmar Pharmaceuticals and MD Anderson Initiate new phase two clinical trial of VAL-083 for mgmt-unmethylated recurrent Glioblastoma Multiforme